|
|||
2009-04-21 09:30:00 CEST 2009-04-21 09:30:02 CEST REGULATED INFORMATION Biohit Oyj - Decisions of general meetingRESOLUTIONS OF THE ANNUAL GENERAL MEETING OF BIOHIT OYJBIOHIT OYJ STOCK EXCHANGE RELEASE ON 21 APRIL 2009 AT 10:30 AM RESOLUTIONS OF THE ANNUAL GENERAL MEETING OF BIOHIT OYJ The Annual General Meeting (AGM) of Biohit Oyj held on 20 April 2009 approved the financial statements of the Biohit Group and the parent company, and discharged the members of the Board of Directors and the president and CEO from liability for the financial year 2008. Distribution of dividends In accordance with the proposal by the Board of Directors the AGM decided that no dividends be paid for the financial year 2008, and that the profit of EUR 945,125.10 be transferred to the retained profit and loss account. Members of the Board of Directors The AGM decided that the number of members of the Board of Directors is six (6). Furthermore, the AGM elected Professor Reijo Luostarinen, Professor Mikko Salaspuro, Professor Osmo Suovaniemi, MSc (Engin.), MBA Kalle Kettunen, BSc (Econ.) Jukka Ant-Wuorinen and MSc (Soc. Sc.) Eero Lehti as members of the Board until the end of the next AGM. Additionally, the AGM decided that the chairman of the Board of Directors would be paid a monthly fee of EUR 1,550 and the ordinary members would be paid a monthly fee of EUR 1,200. Auditors The AGM elected authorized public accountants Ernst & Young Oy as the company's auditors, with APA Erkka Talvinko as the head auditor, until the end of the next AGM. All decisions of the AGM were made unanimously. The minutes of the AGM are available for review by shareholders by 24 April 2009 at the company's website www.biohit.com/investors and the corporate headquarters of Biohit; address Laippatie 1, 00880 Helsinki. Board of Directors of Biohit Oyj Additional information: Osmo Suovaniemi, M.D., Ph.D., Professor President & CEO Tel: +358-9-773 861 GSM: +358-40-745 5605 Email: osmo.suovaniemi@biohit.com Distribution: Helsinki Exchanges Central storage facility Press www.biohit.com About Biohit Oyj Biohit Oyj develops, manufactures and markets liquid handling products and diagnostic test systems for use in research, health care and industrial laboratories. Liquid handling products include electronic and mechanical pipettes and dispensers, and disposable tips, as well as pipette maintenance and calibration services. Diagnostics business comprises products and analysis systems for diagnosing, screening and prevention of gastrointestinal diseases, e.g. the blood-sample based GastroPanel and GastroView, for diagnosing diseases of the stomach and associated risks, as well as quick tests for the diagnosis of lactose intolerance, H. pylori infection and fecal occult blood. Biohit Group employs 370 people in 8 countries. Biohit Oyj is headquartered in Finland. Biohit has subsidiaries in France, Germany, the UK, Russia, China, Japan and the USA. Additionally, Biohit's products are sold by approximately 450 distributors in 70 countries. Biohit's share (BIOBV) is quoted on NASDAQ OMX Helsinki. Read more at www.biohit.com |
|||
|